Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studySalim Yusuf, Gilles R. Dagenais, Andrew Mente et al.|The Lancet|2019Cited by 2k
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Salim Yusuf, Gholamreza Roshandel et al.|The Lancet|2021Cited by 148